Valeo Financial Advisors’s PAVmed PAVM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-704
Closed -$39.1K 713
2024
Q1
$39.1K Hold
704
﹤0.01% 638
2023
Q4
$87.1K Sell
704
-12
-2% -$1.41K ﹤0.01% 613
2023
Q3
$94.9K Hold
716
﹤0.01% 592
2023
Q2
$131K Hold
716
0.01% 562
2023
Q1
$120K Sell
716
-51
-7% -$10.7K 0.01% 574
2022
Q4
$166K Hold
767
0.01% 497
2022
Q3
$297K Hold
767
0.02% 345
2022
Q2
$323K Hold
767
0.02% 324
2022
Q1
$456K Buy
767
+61
+9% +$45.3K 0.02% 346
2021
Q4
$781K Buy
706
+22
+3% +$47.8K 0.04% 224
2021
Q3
$2.63M Buy
684
+18
+3% +$56.8K 0.15% 91
2021
Q2
$1.92M Buy
666
+34
+5% +$80.3K 0.12% 115
2021
Q1
$1.26M Sell
632
-106
-14% -$159K 0.06% 160
2020
Q4
$704K Buy
+738
New +$631K 0.04% 196
2020
Q1
Sell
-9
Closed -$5K 1879
2019
Q4
$5K Buy
9
+7
+350% +$2.92K ﹤0.01% 1286
2019
Q3
$1K Hold
2
﹤0.01% 1470
2019
Q2
$1K Buy
+2
New +$1.06K ﹤0.01% 1483

Other funds holding PAVM

Valeo Financial Advisors's PAVM Position: Q2 2024 in Review

Valeo Financial Advisors sold out of PAVmed (PAVM) in Q2 2024, closing a stake of 704 shares — an estimated $39.1K sold.

Valeo Financial Advisors first reported a position in PAVM in Q2 2019 and held it in 17 quarters. The position peaked at $2.63M in Q3 2021. 22 funds tracked by Wall St. Rank hold PAVM as of Q2 2024.

  • Valeo Financial Advisors reported no remaining PAVmed position as of Q2 2024 after selling out during the quarter.
  • Valeo Financial Advisors sold 704 PAVmed shares in Q2 2024, an estimated $39.1K.
  • Valeo Financial Advisors first reported a position in PAVmed in Q2 2019 and held it in 17 quarters.
  • Valeo Financial Advisors's PAVmed position peaked at $2.63M in Q3 2021.
  • 22 funds tracked by Wall St. Rank held PAVmed as of Q2 2024.

Based on Valeo Financial Advisors's 13F filing for Q2 2024, filed 10 Jul 2024.